genomics African Cancer Genome Registry Seeks Participants to Improve Understanding of Higher Risk, Mortality The study will recruit about 2,000 patients of African ancestry to identify genomic, socioeconomic, and lifestyle factors associated with cancer. GeneCentric Begins Study to Validate RNA Gene Signature Test in Bladder Cancer GeneCentric investigators will assess the ability of the FGFR predictive response signature to identify bladder cancer patients who may benefit from targeted therapy. Cofactor Quickly Moving Immunotherapy Predictive Test to Market With Data From Intermountain Spinout Premium Culmination Bio's 4.5 million biospecimens and longitudinal omics and clinical data may help Cofactor rapidly advance the OncoPrism assay into multiple cancer types. Formerly PerkinElmer, Revvity Discusses Plans, Goals as Dx, Life Science Firm Premium The firm reported Thursday its Q1 revenues declined 30 percent as COVID-19 revenues dwindled but non-COVID organic revenues grew 6 percent. New NASEM Report Suggests Dropping Race, Ethnicity Tags From Genetic, Genomic Studies In the report, an NASEM committee has compiled a list of recommendations for genetic researchers to ensure appropriate usage of population descriptors. Mar 14, 2023 New Single-Cell Genome, Transcriptome Sequencing Technique Delivers Better Bang For Buck Premium Mar 1, 2023 Agilent Technologies Fiscal Q1 Revenues Rise 5 Percent Feb 9, 2023 Startup mDetect Readying Trial of Methylation-Based Liquid Biopsy for Breast Cancers Premium Jan 31, 2023 International Commission to Expand Molecular Testing Access for Cancer Patients Nov 16, 2022 Aussie Variant Classification Effort Aims to Reduce Uncertainty in Hereditary Blood Cancer Diagnosis Premium Oct 19, 2022 ProPhase Labs Subsidiary, G42 Healthcare Enter Strategic Collaboration for Genomics Sep 19, 2022 Chan Zuckerberg Initiative Commits $46M to Support Historically Black Medical Schools Aug 29, 2022 Lack of Cell Line Genetic Diversity Impacts Research, Clinical Translation of Results Premium May 24, 2022 Agilent Technologies Fiscal Q2 Revenues Rise 5 Percent May 4, 2022 Bio-Techne Fiscal Q3 Revenues Rise 19 Percent Feb 22, 2022 Agilent Fiscal Q1 Revenues Rise 8 Percent; Firm Increases FY22 Guidance Feb 1, 2022 Bio-Techne Fiscal Q2 Revenues Rise 20 Percent Nov 22, 2021 Agilent Q4 Revenues Rise 12 Percent Nov 2, 2021 Bio-Techne Fiscal Q1 Revenues Rise 26 Percent Aug 17, 2021 Agilent Technologies Q3 Revenues Rise 26 Percent Jul 20, 2021 Agilent Technologies, Thomas Scientific Ink Distribution Agreement for Genomics Products Jun 17, 2021 Weill Cornell Medicine Launches $1.5B Program to Advance Medical Research Jan 7, 2021 NHGRI Sets Plan to Diversify Genomics Workforce Nov 13, 2020 SARS-CoV-2 Genome Study Reveals Dominant Strain Oct 28, 2020 Q&A: NHGRI's Eric Green on Advancements and Ongoing Challenges in Genomics Premium Load More Breaking News Compact Gene Editing Enzyme May Improve Success Rates of Gene Therapies People in the News at Veracyte, Invitae, Mount Sinai, InterVenn Biosciences, Applied BioCode, More New Products Posted to GenomeWeb: Qiagen, IDT, Revvity, Mission Bio, NRichDx, More FDA Releases Proposed Rule for Oversight of Laboratory-Developed Tests CStone Pharmaceuticals, Genetron Companion Diagnostic Receives NMPA Approval The Scan Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants. Small Study of Gene Editing to Treat Sickle Cell Disease In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms. Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema. Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.